Orion Biotech Opportunities Corp. | Business Finance | Business Contracts

Forward Purchase Agreement, dated May 12, 2021, between the Company and Orion Sponsor Holdings, LLC (Filed With SEC on May 18, 2021)

Registration and Shareholder Rights Agreement, dated May 12, 2021, among the Company, the Sponsor and certain directors of the Company (Filed With SEC on May 18, 2021)

Investment Management Trust Account Agreement, dated May 12, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on May 18, 2021)

Private Placement Warrants Purchase Agreement, dated May 12, 2021, between the Company and the Sponsor (Filed With SEC on May 18, 2021)

Warrant Agreement, dated May 12, 2021, between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on May 18, 2021)

Underwriting Agreement, dated May 12, 2021, between the Company and Cantor Fitzgerald & Co (Filed With SEC on May 18, 2021)

Form of Forward Purchase Agreement between the Registrant and Purchaser (Filed With SEC on April 12, 2021)

FORWARD PURCHASE AGREEMENT (Filed With SEC on April 1, 2021)

Form of Underwriting Agreement (Filed With SEC on April 1, 2021)

Securities Subscription Agreement, dated February 8, 2021, between the Registrant and the Sponsor (Filed With SEC on April 1, 2021)

Promissory Note, dated as of February 8, 2021, issued to the Sponsor (Filed With SEC on April 1, 2021)

Form of Private Placement Warrants Purchase Agreement between the Registrant and the Sponsor (Filed With SEC on April 1, 2021)

Form of Registration and Shareholder Rights Agreement among the Registrant, the Sponsor and the Holders signatory thereto (Filed With SEC on April 1, 2021)

Form of Investment Management Trust Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on April 1, 2021)

Form of Warrant Agreement between Continental Stock Transfer& Trust Company and the Registrant (Filed With SEC on April 1, 2021)

Specimen Warrant Certificate (Filed With SEC on April 1, 2021)

Specimen Ordinary Share Certificate (Filed With SEC on April 1, 2021)

Orion Biotech Opportunities Corp. (25) | Business Finance (17)